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Abstract 
We have shown previously that BHV-1 infection activates Erk1/2 signaling. Here, we show that BHV-1 provoked an 
early-stage transient and late-stage sustained activation of JNK, p38MAPK and c-Jun signaling in MDBK cells. C-Jun 
phosphorylation was dependent on JNK. These early events were partially due to the viral entry process. Unexpect-
edly, reactive oxygen species were not involved in the later activation phase. Interestingly, only activated JNK facili-
tated the viral multiplication identified through both chemical inhibitor and siRNA. Collectively, this study provides 
insight into our understanding of early stages of BHV-1 infection.
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and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
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Introduction
Bovine herpesvirus 1 (BHV-1), an enveloped virus 
belonging to the alphaherpesvirus subfamily, infects cat-
tle of all ages and breeds worldwide. BHV-1-induced 
immune suppression initiates the secondary bacterial 
infection and leads to bovine respiratory disease com-
plex, ultimately resulting in high mortality [1, 2]. The 
viral infection may also result in abortions, inflammation, 
conjunctivitis, and severe neonatal diseases. It costs the 
US cattle industry approximately 3 billion dollars annu-
ally [3].
Mitogen-activated protein kinases (MAPK), a family of 
serine/threonine protein kinases, are mainly divided into 
three family members including the extracellular signal-
regulated kinase 1 and 2 (Erk1/2), c-Jun NH2-terminal 
kinase (JNK) and p38MAPK [4, 5]. They phosphorylate 
specific substrates at serine and/or threonine residues, 
and thereby transduce signals from the cell membrane 
to the nucleus in response to a wide range of stimuli, to 
participate in a diverse array of cellular programs includ-
ing cell mitosis, proliferation, motility, metabolism, and 
other fundamental biological processes [6, 7]. Accu-
mulated evidence indicates that MAPK pathways are 
involved in inflammatory response via activating the tar-
get genes of inflammatory mediators [8–10]. Moreover, 
inhibitors targeting p38MAPK and JNK pathways have 
been developed for anti-inflammatory therapeutics, and 
the data from preclinical treatments have validated their 
prominent anti-inflammatory effect [11].
Since the MAPK cascades broadly regulate cellu-
lar biology function, it is not surprising that they are 
involved in the pathological responses of hosts to viral 
infection. For example, MAPK pathways were impli-
cated in inflammatory response by the infection of 
influenza virus and HSV-1 [12–15]. The employment 
of MAPK inhibitors emerges as an attractive strategy to 
reduce both viral load and the level of pro-inflammatory 
cytokines to definitely control viral infection. We know 
that BHV-1 infection activates MAPK/Erk1/2 signaling 
in MDBK cells [16]. However, little is known about the 
response of p38MAPK and JNK in BHV-1 infection.
The aim of this study was to determine whether BHV-1 
infection could alter p38MAPK and JNK pathways in 
MDBK cells. We found that BHV-1 infection of MDBK 
cells indeed activated both p38MAPK and JNK pathways. 
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However, only the JNK pathway was essential to viral 
replication. We also defined that c-Jun was exclusively 
activated by viral infection through JNK. Unexpect-
edly, BHV-1 infection-activated MAPK pathways was 
not through a reactive oxygen species (ROS)-dependent 
mechanism, though ROS is widely reported to be an acti-
vator of MAPK pathways during numerous virus infec-
tions, such as by HSV-1 [17, 18]. These studies partially 
address the importance of MAPK pathways in BHV-1 
infection induced inflammatory response.
Materials and methods
Antibodies and reagents
Antibodies against phospho-JNK (Thr183/Tyr185), 
phospho-p38MAPK (Thr180/Tyr182), Phospho-p44/42 
MAPK (Erk1/2)  (Thr202/Tyr204), phospho-c-Jun 
(Ser73), JNK, p38MAPK, p44/42 MAPK (Erk1/2), c-Jun, 
and GAPDH, as well as HRP labeled secondary antibod-
ies anti-mouse IgG or anti-rabbit IgG were purchased 
from Cell Signaling Technology (Beverly, MA, USA). 
N-Acetyl-l-cysteine (NAC) was bought from Sigma-
Aldrich (St. Louis, MO, USA). U0126, SB203580, and 
SP600125 were purchased from Cell Signaling Technol-
ogy. BHV-1 VP16 antibody is kindly provided by Prof. 
Vikram Misra at the University of Saskatchewan [19].
Virus and cell cultures
MDBK cells (provided by Dr Leonard J. Bello, University 
of Pennsylvania) were maintained at 37  °C in 5% CO2 
in DMEM (Gibco BRL) supplemented with 10% horse 
serum (HyClone Laboratories, Logan, UT, USA). BHV-1 
Colorado1 strain (provided by Dr Leonard J. Bello, Uni-
versity of Pennsylvania) used for this study was propa-
gated in MDBK cells. Aliquots of virus stocks were stored 
at −70 °C until use. The virus was titrated in MDBK cells 
with results expressed as TCID50 calculated using the 
Reed-Muench formula. The inactivation of BHV-1 by 
UV-irradiation was performed as previously described 
[16]. Effective inactivation of viruses was confirmed by 
virus titer assay in MDBK cells.
siRNA knockdown
siRNA1–3 targeting JNK1, and siRNA4–6 targeting 
JNK2 as well as the control siRNA were purchased from 
Genepharma (Shanghai, China). SiRNA transfection 
was performed with transfection reagent siRNA-Mate 
(Genepharma) according to the manufacturer’s specifi-
cations. Efficiency of these siRNA were characterized by 
Western blotting.
Inhibition of viral replication by chemical inhibitors
Confluent MDBK cells in 24-well plates were pre-
treated with the detected inhibitors at the indicated 
concentrations for 1 h at 37 °C, followed by BHV-1 infec-
tion at MOI of 1 for 1  h. After extensive washing with 
PBS, the cells were replaced with fresh medium DMEM 
(400 μL) with or without chemicals and cultured in a CO2 
incubator at 37 °C. The virus yield was titrated by TCID50 
assay.
Western blot analysis
Monolayers of MDBK cells in 60-mm dishes were serum 
starved overnight, mock-infected or infected with BHV-1 
(MOI = 10) at 37 °C for 0.5, 1, 2, 4, 8, 12 and 24 h. Cell 
lysates were prepared with lysis buffer (1% Triton X-100, 
50  mM sodium chloride, 1  mM EDTA, 1  mM EGTA, 
20 mM sodium fluoride, 20 mM sodium pyrophosphate, 
1  mM phenylmethylsulfonyl fluoride, 0.5  g/mL leupep-
tin, 1  mM benzamidine, and 1  mM sodium orthovana-
date in 20 mM Tris–HCl, pH 8.0) at the indicated time 
points. To analyze the effect of detected inhibitors on the 
designated signaling, MDBK cells were exposed to the 
corresponding chemicals through virus infection plus a 
pretreatment for 1 h before virus inoculation. To analyze 
the effect of siRNA on the designated signaling, MDBK 
cells were transfected with siRNA and incubated for 48 h, 
then infected with BHV-1 for the indicated time length 
at 37 °C.
Cell lysates were separated on 8 or 10% SDS–poly-
acrylamide gels and transferred to a polyvinylidene dif-
luoride (PVDF) membrane (Bio-rad, CA, USA). After 
blocking with 5% nonfat milk in Tris-buffered saline 
(TBS) buffer containing 0.05% Tween 20 (TBST), the 
membrane was incubated with respective primary anti-
bodies, and followed by HRP-conjugated secondary anti-
bodies in the blocking reagent. After extensive washing 
with TBST, immune reactive bands were detected by film 
exposure after enhanced chemiluminescence (ECL) reac-
tion (Millipore, USA).
Results
We previously reported that BHV-1 infection induces 
the activation of MAPK/Erk1/2 signaling in MDBK cells 
[16]. To identify whether JNK and p38MAPK signal-
ing were involved in BHV-1 infection of MDBK cells, 
we first examined the kinetics of phosphorylated JNK 
and p38MAPK after BHV-1 virus infection using West-
ern blotting. To see the burst effect of virus infection on 
the detected signaling pathways, serum starved MDBK 
cells were infected with BHV-1 at a high MOI of 10. 
As a result, the levels of both phospho-JNK (Thr183/
Tyr185) and phospho-p38MAPK (Thr180/Tyr182) were 
dramatically elevated in a two-tiered manner following 
BHV-1 infection (Figure 1A). The first tier was transiently 
increased at the early stage of virus infection (Fig-
ure  1A, 0.5 hpi). The second wave was sustained at the 
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later stage of infection (Figure 1A, 12 and 24 hpi). Obvi-
ously, the alteration of phosphorylated p38MAPK or JNK 
was neither due to overexpression of total p38MAPK 
(or JNK) nor to a high amount of protein loading (Fig-
ure 1A). Here, the lytic cycle viral protein VP16 of BHV-1 
was detected to identify the kinetics of viral infection. 
Interestingly, the kinetics of the second tier of activated 
p38MAPK and JNK correlated with that of viral protein 
VP16 expression (Figure 1A). It is highly possible that the 
de novo viral protein expression and/or DNA replication 
account for the second tier of activated p38MAPK and 
JNK.
Considering that the early-transient activation of both 
p38MAPK and JNK appeared as early as 0.5 hpi, UV-
irradiation inactivated virus could enter cells but not 
initiate subsequent genomic replication nor translation. 
We employed the UV-irradiation inactivated virus to 
explore the role of the viral entry process on these acti-
vations. UV-irradiation inactivated viruses were gener-
ated with infectious virus exposed to a 30 W UV light at a 
distance of 10 cm for 1 h. Complete inactivation of virus 
was confirmed with a virus titer assay (data not shown). 
MDBK cells were inoculated with the infectious virus 
(MOI  =  10) or equal amounts of UV-inactivated virus 
in parallel for 0.5  h. As shown in Figure  1B, UV-irradi-
ated BHV-1 induced similar levels of p38MAPK and JNK 
activation when compared to functional BHV-1, sug-
gesting that an early step(s) of viral infection would be 
responsible for these events.
Though we generated the virus stocks without serum 
in the cell culture, both cell debris or growth factors 
were still present in the crude virus, which may have 
stimulated JNK and p38MAPK signaling. The superna-
tant from uninfected cell culture was obtained in par-
allel to the virus stock. MDBK cells were treated with 
either supernatant of uninfected cell culture or crude 
virus at 37  °C for 0.5  h, the phosphorylation of both 
JNK and p38MAPK was detected using Western blot-
ting. As a result, the supernatant of uninfected cell cul-
ture could not induce apparent activation of both JNK 
and p38MAPK (Figure  1C). It ruled out the possibility 
that the activation of JNK and p38MAPK signaling by 
UV-inactivated virus was due to the cellular debris or the 
presence of growth factors in the medium.
To investigate the role of p38MAPK and JNK path-
ways in viral amplification, chemical inhibitors SP600125 
and SB203580 specific for JNK and p38MAPK, were 
respectively employed to treat MDBK cells during the 
virus infection. Proper concentration for each inhibi-
tor that showed no cytotoxicity to MDBK cells was 
selected based on the specifications and 3-(4,5-dime-
thyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide 
Figure 1 Biphasic activation of both JNK and p38MAPK pathway in BHV-1 infected MDBK cells. A Time course of altered phospho-
JNK(Thr183/Tyr185) and phosphor-p38MAPK(Thr180/Tyr182) following BHV-1 infection. Growth arrested MDBK cells were mock infected or infected 
with BHV-1 at an MOI of 10. At the indicated time points, cells were lysed and subjected to Western blotting analysis using the indicated antibod-
ies. B UV-irradiation inactivated virus also induced activation of both JNK and p38MAPK. MDBK cells were infected with BHV-1 (MOI = 10) or with 
equal amounts of UV-irradiation inactivated virus for 30 min. The cells were lysed for Western blotting. C Uninfected cell lysates could not stimulate 
p38MAPK and JNK signaling. To get uninfected cell lysates and crude virus, MDBK cells were mock infected or infected with BHV-1 (MOI = 1) with-
out serum in the medium. At 48 hpi, the cell cultures were subjected to frozen-thawing and centrifugation at 15 000 rpm for 10 min. The superna-
tants were collected and used for the treatment of MDBK cells. At 0.5 h post-treatment, the cells were lysed for Western blotting analysis. Data are 
representative results of three independent experiments.
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(MTT) assay (data not shown). The treatment with JNK 
specific inhibitor SP600125 at 6.25, 12.5 and 25  μM 
strongly reduced the virus production ranging from ~1 to 
~1.6 logs (Figure 2A). Although p38MAPK was activated 
by BHV-1 infection, the p38MAPK specific inhibitor 
SB203580 showed no apparent effect on viral replication 
(Figure 2B). The data suggest that JNK pathways play an 
important role in viral amplification.
The JNK are encoded by three separate genes (JNK1, 
2, and 3), which are spliced alternatively to create 10 
JNK isoforms that are either 54  or 46  kDa in size [20]. 
In mammalians, JNK1 and JNK2 are widely expressed, 
whereas JNK3 expression is largely restricted to the 
brain [21, 22]. Chemical inhibitors might exert off-target 
effects. We used siRNA-mediated knock down to address 
the specific role of JNK in BHV-1 replication. MDBK cells 
were transiently transfected with siRNA1–3 targeting 
JNK1, and siRNA4–6 targeting JNK2 as well as the con-
trol siRNA (provided by Genepharma, Shanghai, China). 
Of these detected siRNA, only siRNA1 could apparently 
reduce the expression of JNK as determined by West-
ern blotting (Figure  2C). Next, MDBK cells in 24-well 
plates were transfected with siRNA1, siRNA2 and control 
siRNA, respectively, and at 48  h post-transfection they 
were infected with BHV-1 (MOI  =  1). The virus yield 
was determined at 24 hpi with TCID50 assay. As a result, 
comparing to either control siRNA or siRNA2, siRNA1 
moderately decreased viral titer by ~0.5 log (Figure 2D). 
Although the inhibitory effect of siRNA1 was not as 
strong as the inhibitor SP600125 on viral replication, 
knockdown of JNK1 consistently decreased the virus 
infection. In addition, siRNA transfection reduced the 
level of phosphorylated JNK (Figure 2E), which corrobo-
rated the result that BHV-1 infection activated JNK, and 
knockdown of JNK1 reduced BHV-1 replication. Collec-
tively, these results imply that JNK1 may be involved in 
BHV-1 replication.
Upon activation, the phosphorylated JNK form dimers 
and enter the nucleus to activate target genes through its 
effects on c-Jun, ATF-2, and other transcription factors 
[23]. We therefore subsequently monitored the kinet-
ics of activated c-Jun during BHV-1 infection through a 
Western blotting assay. The elevated levels of phospho-
rylated c-Jun (Ser73) were observed at both early and 
later stages of virus infection (Figure  3A). Exposure to 
UV-inactivated virus rendered an early event of c-Jun 
phosphorylation, as determined at 0.5 hpi at a level com-
parable to that obtained with functional virus (Figure 3B). 
It implies that BHV-1 infection activated c-Jun pathways, 
and viral early entry steps could be responsible for the 
early wave of activation.
Although c-Jun indeed is a canonical downstream tar-
get of JNK, accumulated data has shown that c-Jun can 
also be activated by other MAPK signaling axes such as 
by p38MAPK and Erk1/2. For example, JNK independ-
ent phosphorylation of c-Jun has been demonstrated in 
numerous cells stimulated with phorbol 12-myristate 
13-acetate (PMA) [24], and c-Jun-dependent microglial 
inflammatory response following irradiation is medi-
ated by Erk1/2 but not by JNK [25]. Here, we chemically 
inhibited JNK signaling with SP600125, p38MAPK sign-
aling with SB203580 and Erk1/2 signaling with U0126, 
to elucidate whether there was a dialog between c-Jun 
and p38MAPK and Erk1/2. MDBK cells were pretreated 
with compounds at indicated concentrations for 1 h and 
then infected with BHV-1 (MOI  =  10) in the presence 
of inhibitors. At 0.5 and 24 hpi, the cells were lysed and 
p-c-Jun was detected by Western blotting. Interestingly, 
BHV-1 induced phosphorylation of c-Jun was uniquely 
inhibited by JNK inhibitor SP600125 (Figures  3B  and 
C). This indicates that JNK is the unique stimulator for 
BHV-1-activated c-Jun signaling. Similarly, it has been 
reported that treatment of HSV-1-infected Vero cells 
with SB203580 results in minor effects on c-Jun activa-
tion [26].
Reactive oxygen species are key signaling molecules 
that play an important role in the progression of inflam-
matory disorders [27]. Our recent data indicate that 
BHV-1 infection stimulates ROS production to facilitate 
viral infection and mediate mitochondrial dysfunction 
[28]. HSV-1 is genetically close to BHV-1, which stimu-
lates MAPK signaling with  a ROS-dependent manner 
[10]. Therefore, the relation between ROS production 
and MAPK activation induced by BHV-1 infection was 
investigated. MDBK cells were treated with ROS scaven-
ger NAC [29] at a concentration of 5 and 1 mM, respec-
tively, and infected with virus (MOI = 10). At 24 hpi the 
cells were lysed for Western blotting to detect the phos-
phorylation of p38MAPK, JNK, Erk1/2 and c-Jun. As 
a result, none of them were blocked by ROS scavenger 
NAC (Figure 4). This suggests that BHV-1 stimulated the 
three MAPK signaling, p38MAPK, Erk1/2 and JNK/c-
Jun with a ROS-independent manner, which was distinct 
from that of the genetic closely related HSV-1.
Discussion
The canonical MAPK pathways implicated in various 
inflammatory responses have been reported to be modi-
fied by diverse viruses to support productive replica-
tion, control cell proliferation, suppress cell apoptosis, 
or induce cytokine production and inflammation [10, 
30, 31]. For example, the activation of p38MAPK and 
Erk1/2 is required for the nuclear export of viral ribo-
nucleoprotein complexes [32, 33]. Here, we established 
that both p38MAPK and JNK signaling were activated 
in BHV-1-infected MDBK cells (Figure 1). Together with 
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our previous data [16], we knew that in BHV-1 infected 
MDBK cells the three canonical MAPK signaling includ-
ing p38 MAPK, JNK and Erk1/2 were activated. BHV-1 
and HSV-1 belong to the Alphaherpesvirinae subfamily 
and share a number of biological properties. However, 
HSV-1 infection activates both p38 MAPK and JNK 
signaling, but reduces Erk1/2 signaling [14, 34, 35]. 
Obviously, these MAPK pathways were differentially 
manipulated by BHV-1 and HSV-1. It is reasonable that 
the discriminatory controlling of MAPK pathways would 
Figure 2 The JNK but not p38MAPK signaling related to BHV-1 replication. A, B JNK inhibitor inhibited BHV-1 replication. MDBK cells were 
first pretreated with inhibitor SP600125 A specific for JNK or inhibitor SB203580 B specific for p38MAPK at various concentrations for 1 h, and then 
infected with BHV-1 at an MOI of 1. At 24 hpi, virus yield was titrated using the TCID50 assay. C Screening siRNA target for JNK1 and JNK2. MDBK 
cells in 6-well plates were transfected with the indicated siRNA of 100 pM using transfection reagent siRNA-Mate (Genepharma) according to the 
specifications. At 48 h post transfection, the cells were lysed and subjected to Western blotting with antibody against JNK. D Knock down of the 
expression of JNK1 with siRNA1 moderately inhibited BHV-1 replication. MDBK cells in 24-well plates were transfected with siRNA1, siRNA3 and 
control siRNA of 20 pM using transfection reagent siRNA-Mate. At 48 h post transfection, the cells were infected with BHV-1 at MOI of 1 for 1 h, 
after extensive washing with PBS, fresh medium was replaced for further incubation of 24 h. Virus yield was tittered with TCID50. The data are from 
three independent experiments. Statistical analyses were performed using the Student’s t test (P < 0.05 vs. control). E Knockdown JNK1 by siRNA1 
reduced JNK1 phosphorylation induced by BHV-1 infection. MDBK cells in 6-well plates were transfected with siRNA1 and control siRNA, respec-
tively. At 48 h post-transfection, the cells were infected with BHV-1 at MOI of 10 for 0.5 h. The cell lysates were prepared for Western blotting analysis. 
Data are representative of two repeats.
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produce different effects on virus pathogenicity. In the 
future it would be interesting to study the mechanisms of 
the differential manipulation of MAPK pathways by these 
two viruses.
Since the UV-inactivated viral particles could enter 
host cells but not complete subsequent gene transcrip-
tion, they could still activate these MAPK signaling at 0.5 
hpi. Based on this data and our previous report [16], we 
suggest that the viral entry process may partially account 
for the enhanced phosphorylation of these three MAPK 
signaling. ROS are important inflammatory media-
tors, which are recognized as secondary messengers to 
activate a variety of cellular signaling pathways such as 
p38MAPK and Erk1/2 after HSV-1 infection of murine 
microglial cells [10]. We recently reported that BHV-1 
infection increases ROS production, which contributes to 
viral replication [28]. Considering that BHV-1 and HSV-1 
are genetically closely related, ROS is a putative compo-
nent responsible for BHV-1 activated MAPK pathways. 
However, here we found that ROS was not accounted for 
BHV-1-stimulated phosphorylation of p38MAPK, Erk1/2 
and JNK (Figure  4). So the activation of these MAPK 
pathways by BHV-1was not mediated by ROS.
JNK activation may exert viral-supportive or antiviral 
effect for diverse viruses. For example, JNK knockout 
mouse embryonic fibroblasts (MEF) were more suscep-
tible to oncolytic vaccinia virus infection than wild-type 
MEF [36]. In contrast, JNK inhibitor SP600125 possesses 
a strong inhibitory effect on viral replication of either 
Figure 3 The activation of c-Jun following BHV-1 infection depended on JNK signaling. A Time course of altered phosphorylation of c-Jun 
at Ser73 following BHV-1 infection. Growth arrested MDBK cells were mock infected or infected with BHV-1 at an MOI of 10. At the indicated time 
points, the cells were lysed and subjected to Western blotting analysis using specific antibodies. B UV-irradiation inactivated virus still induced acti-
vation of c-Jun. MDBK cells were infected with BHV-1 (MOI = 10) or with equal amounts of UV-irradiation inactivated virus for 30 min. The cells were 
lysed for Western blotting. C, D C-Jun was activated by BHV-1 through JNK. MDBK cells were first pretreated with inhibitor SP600125, SB203580 and 
U0126 specific for JNK, p38MAPK and Erk1/2 signaling at the indicated concentrations for 1 h, and then infected with BHV-1 at an MOI of 10. At 0.5 
and 24 hpi, the cells were respectively lysed for Western blotting to detect the phospho-c-Jun. Data are representative results of three independent 
experiments.
Figure 4 The effect of ROS scavenger NAC on BHV-1 stimu-
lated MAPK pathways. MDBK cells were first mock pretreated with 
DMSO control or pretreated with NAC at the indicated concentra-
tions for 1 h, then mock infected or infected with BHV-1 at an MOI 
of 10 along with NAC or DMSO control. At 24 hpi, cell lysates were 
prepared and phosphorylated forms of JNK, c-Jun, p38MAPK and 
Erk1/2 were detected using Western blotting. Data represent three 
independent experiments.
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highly pathogenic avian virus strain A/FPV/Bratislava/79 
(H7N7) or the pandemic swine-origin influenza virus A/
Hamburg/4/09 (H1N1v) [37]. Here, we elucidated that 
only JNK was required to support BHV-1 replication, but 
p38MAPK could not (Figures  2A, B, D). Interestingly, 
both P38 MAPK and JNK pathways are important for 
HSV-1 gene expression and viral propagation [26, 34, 38]. 
So the MAPK pathways are discriminately controlled by 
BHV-1 and HSV-1 for viral replication.
In summary, for the first time we elucidated that in 
BHV-1 infected MDBK cells, all three major MAPK 
pathways are activated in response to viral infection, 
but JNK signaling was uniquely required for viral rep-
lication. Interestingly, we provide evidence that BHV-1 
activated the MAPK pathways with a ROS-independent 
mechanism, which was different from that with HSV-1. 
The potential participation of these pathways in diverse 
processes of BHV-1 infection would provide valu-
able information towards comprehending the infection 
and inflammatory mechanism of BHV-1 infection in 
bovines.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LZ participated in design of the study, analyzed the data and prepared the 
manuscript. CY, LH and XD carried out the experiments, DZ cultured the cells. 
JW revised the manuscript, GZ coordinated the research. All authors read and 
approved the final manuscript.
Acknowledgements
The authors are grateful to Dr Leonard J. Bello, University of Pennsylvania, 
for providing the MDBK cells and the Colorado 1 strain of BHV-1, and thanks 
for Prof. Vikram Misra from University of Saskatchewan for kindly providing 
the antibody against BHV-1 VP16. This research was supported by Chinese 
National Science Foundation Grant (No. 31472172), the Priority Academic 
Program Development of Jiangsu Higher Education Institutions (PAPD and 
TAPP). Partly supported by the Grant Nos. BE2014358 and 14KJA230001 from 
Jiangsu province.
Author details
1 College of Veterinary Medicine and Jiangsu Co-innovation Center for Preven-
tion and Control of Important Animal Infectious Diseases and Zoonoses, 
Yangzhou University, 48 Wenhui East Road, Yangzhou 225009, China. 2 The Test 
Center of Yangzhou University, 48 Wenhui East Road, Yangzhou 225009, China. 
Received: 24 March 2016   Accepted: 28 June 2016
References
 1. Tikoo SK, Campos M, Babiuk LA (1995) Bovine herpesvirus 1 (BHV-1): biol-
ogy, pathogenesis, and control. Adv Virus Res 45:191–223
 2. Muylkens B, Thiry J, Kirten P, Schynts F, Thiry E (2007) Bovine herpesvirus 1 
infection and infectious bovine rhinotracheitis. Vet Res 38:181–209
 3. Jones C, Chowdhury S (2007) A review of the biology of bovine herpesvi-
rus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease 
complex and development of improved vaccines. Anim Health Res Rev 
8:187–205
 4. Hazzalin CA, Mahadevan LC (2002) MAPK-regulated transcription: a 
continuously variable gene switch? Nat Rev Mol Cell Biol 3:30–40
 5. Dong W, Wei X, Zhang F, Hao J, Huang F, Zhang C, Liang W (2014) A 
dual character of flavonoids in influenza a virus replication and spread 
through modulating cell-autonomous immunity by MAPK signaling 
pathways. Sci Rep 4:7237
 6. Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a 
family of protein kinases with diverse biological functions. Microbiol Mol 
Biol Rev 68:320–344
 7. Wada T, Penninger JM (2004) Mitogen-activated protein kinases in apop-
tosis regulation. Oncogene 23:2838–2849
 8. Panteva M, Korkaya H, Jameel S (2003) Hepatitis viruses and the MAPK 
pathway: is this a survival strategy? Virus Res 92:131–140
 9. Xie J, Zhang S, Hu Y, Li D, Cui J, Xue J, Zhang G, Khachigian LM, Wong J, 
Sun L, Wang M (2014) Regulatory roles of c-jun in H5N1 influenza virus 
replication and host inflammation. Biochim Biophys Acta 1842:2479–2488
 10. Hu S, Sheng WS, Schachtele SJ, Lokensgard JR (2011) Reactive oxygen 
species drive herpes simplex virus (HSV)-1-induced proinflammatory 
cytokine production by murine microglia. J Neuroinflamm 8:123
 11. Kaminska B (2005) MAPK signalling pathways as molecular targets for 
anti-inflammatory therapy—from molecular mechanisms to therapeutic 
benefits. Biochim Biophys Acta 1754:253–262
 12. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S 
(2001) Influenza virus propagation is impaired by inhibition of the Raf/
MEK/ERK signalling cascade. Nat Cell Biol 3:301–305
 13. Wang X, Tan J, Zoueva O, Zhao J, Ye Z, Hewlett I (2014) Novel pandemic 
influenza A (H1N1) virus infection modulates apoptotic pathways that 
impact its replication in A549 cells. Microbes Infect 16:178–186
 14. Chuluunbaatar U, Roller R, Mohr I (2012) Suppression of extracellular 
signal-regulated kinase activity in herpes simplex virus 1-infected cells by 
the Us3 protein kinase. J Virol 86:7771–7776
 15. Gaur P, Munjhal A, Lal SK (2011) Influenza virus and cell signaling path-
ways. Med Sci Monit 17:RA148–154
 16. Zhu L, Ding X, Zhu X, Meng S, Wang J, Zhou H, Duan Q, Tao J, Schifferli 
DM, Zhu G (2011) Biphasic activation of PI3 K/Akt and MAPK/Erk1/2 
signaling pathways in bovine herpesvirus type 1 infection of MDBK cells. 
Vet Res 42:57
 17. Chen D, Su A, Fu Y, Wang X, Lv X, Xu W, Xu S, Wang H, Wu Z (2015) 
Harmine blocks herpes simplex virus infection through downregulat-
ing cellular NF-kappaB and MAPK pathways induced by oxidative stress. 
Antivir Res 123:27–38
 18. Chen X, Qiao H, Liu T, Yang Z, Xu L, Xu Y, Ge HM, Tan RX, Li E (2012) Inhibi-
tion of herpes simplex virus infection by oligomeric stilbenoids through 
ROS generation. Antivir Res 95:30–36
 19. Misra V, Bratanich AC, Carpenter D, O’Hare P (1994) Protein and DNA ele-
ments involved in transactivation of the promoter of the bovine herpes-
virus (BHV) 1 IE-1 transcription unit by the BHV alpha gene trans-inducing 
factor. J Virol 68:4898–4909
 20. Tsuiki H, Tnani M, Okamoto I, Kenyon LC, Emlet DR, Holgado-Madruga 
M, Lanham IS, Joynes CJ, Vo KT, Wong AJ (2003) Constitutively active 
forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors. 
Cancer Res 63:250–255
 21. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 
103:239–252
 22. Bogoyevitch MA (2006) The isoform-specific functions of the c-Jun 
N-terminal kinases (JNKs): differences revealed by gene targeting. BioEs-
says 28:923–934
 23. Leppa S, Bohmann D (1999) Diverse functions of JNK signaling and c-Jun 
in stress response and apoptosis. Oncogene 18:6158–6162
 24. Humar M, Loop T, Schmidt R, Hoetzel A, Roesslein M, Andriopoulos N, 
Pahl HL, Geiger KK, Pannen BH (2007) The mitogen-activated protein 
kinase p38 regulates activator protein 1 by direct phosphorylation of 
c-Jun. Int J Biochem Cell Biol 39:2278–2288
 25. Deng Z, Sui G, Rosa PM, Zhao W (2012) Radiation-induced c-Jun activa-
tion depends on MEK1-ERK1/2 signaling pathway in microglial cells. PLoS 
One 7:e36739
 26. Karaca G, Hargett D, McLean TI, Aguilar JS, Ghazal P, Wagner EK, Bachen-
heimer SL (2004) Inhibition of the stress-activated kinase, p38, does not 
affect the virus transcriptional program of herpes simplex virus type 1. 
Virology 329:142–156
 27. Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB (2014) Reactive oxy-
gen species in inflammation and tissue injury. Antioxid Redox Signal 
20:1126–1167
Page 8 of 8Zhu et al. Vet Res  (2016) 47:91 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 28. Zhu L, Yuan C, Zhang D, Ma Y, Ding X, Zhu G (2016) BHV-1 induced oxida-
tive stress contributes to mitochondrial dysfunction in MDBK cells. Vet 
Res 47:47
 29. Kang S, Lu K, Leelawattanachai J, Hu X, Park S, Park T, Min IM, Jin MM 
(2013) Virus-mimetic polyplex particles for systemic and inflamma-
tion-specific targeted delivery of large genetic contents. Gene Ther 
20:1042–1052
 30. Mizumura K, Hashimoto S, Maruoka S, Gon Y, Kitamura N, Matsumoto K, 
Hayashi S, Shimizu K, Horie T (2003) Role of mitogen-activated protein 
kinases in influenza virus induction of prostaglandin E2 from arachidonic 
acid in bronchial epithelial cells. Clin Exp Allergy 33:1244–1251
 31. Pleschka S (2008) RNA viruses and the mitogenic Raf/MEK/ERK signal 
transduction cascade. Biol Chem 389:1273–1282
 32. Nencioni L, De Chiara G, Sgarbanti R, Amatore D, Aquilano K, Marcocci 
ME, Serafino A, Torcia M, Cozzolino F, Ciriolo MR, Garaci E, Palamara AT 
(2009) Bcl-2 expression and p38MAPK activity in cells infected with influ-
enza A virus: impact on virally induced apoptosis and viral replication. J 
Biol Chem 284:16004–16015
 33. Marjuki H, Alam MI, Ehrhardt C, Wagner R, Planz O, Klenk HD, Ludwig 
S, Pleschka S (2006) Membrane accumulation of influenza A virus 
hemagglutinin triggers nuclear export of the viral genome via protein 
kinase Calpha-mediated activation of ERK signaling. J Biol Chem 
281:16707–16715
 34. McLean TI, Bachenheimer SL (1999) Activation of cJUN N-terminal 
kinase by herpes simplex virus type 1 enhances viral replication. J Virol 
73:8415–8426
 35. Hargett D, McLean T, Bachenheimer SL (2005) Herpes simplex virus ICP27 
activation of stress kinases JNK and p38. J Virol 79:8348–8360
 36. Hu W, Hofstetter W, Guo W, Li H, Pataer A, Peng HH, Guo ZS, Bartlett DL, 
Lin A, Swisher SG, Fang B (2008) JNK-deficiency enhanced oncolytic 
vaccinia virus replication and blocked activation of double-stranded 
RNA-dependent protein kinase. Cancer Gene Ther 15:616–624
 37. Nacken W, Ehrhardt C, Ludwig S (2012) Small molecule inhibitors of the 
c-Jun N-terminal kinase (JNK) possess antiviral activity against highly 
pathogenic avian and human pandemic influenza A viruses. Biol Chem 
393:525–534
 38. Zachos G, Clements B, Conner J (1999) Herpes simplex virus type 1 
infection stimulates p38/c-Jun N-terminal mitogen-activated protein 
kinase pathways and activates transcription factor AP-1. J Biol Chem 
274:5097–5103
